These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 16838836)
1. Suppression of HIV-1 replication by a combination of endonucleolytic ribozymes (RNase P and tRNnase ZL). Ikeda M; Habu Y; Miyano-Kurosaki N; Takaku H Nucleosides Nucleotides Nucleic Acids; 2006; 25(4-6):427-37. PubMed ID: 16838836 [TBL] [Abstract][Full Text] [Related]
2. Long-term RNase P-mediated inhibition of HIV-1 replication and pathogenesis. Hnatyszyn H; Spruill G; Young A; Seivright R; Kraus G Gene Ther; 2001 Dec; 8(24):1863-71. PubMed ID: 11821940 [TBL] [Abstract][Full Text] [Related]
3. Effective inhibition of HIV-1 replication in cultured cells by external guide sequences and ribonuclease. Endo Y; Miyano-Kurosaki N; Kitano M; Habu Y; Takaku H Nucleic Acids Res Suppl; 2001; (1):213-4. PubMed ID: 12836340 [TBL] [Abstract][Full Text] [Related]
4. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding. Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131 [TBL] [Abstract][Full Text] [Related]
5. High level inhibition of HIV replication with combination RNA decoys expressed from an HIV-Tat inducible vector. Fraisier C; Irvine A; Wrighton C; Craig R; Dzierzak E Gene Ther; 1998 Dec; 5(12):1665-76. PubMed ID: 10023446 [TBL] [Abstract][Full Text] [Related]
6. Design of short external guide sequences (EGSs) for cleavage of target molecules with RNase P. Werner M; Rosa E; George ST Nucleic Acids Symp Ser; 1997; (36):19-21. PubMed ID: 9478194 [TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multitarget anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme. Unwalla H; Chakraborti S; Sood V; Gupta N; Banerjea AC Antiviral Res; 2006 Nov; 72(2):134-44. PubMed ID: 16790281 [TBL] [Abstract][Full Text] [Related]
9. Cross-clade inhibition of HIV-1 replication and cytopathology by using RNase P-associated external guide sequences. Kraus G; Geffin R; Spruill G; Young AK; Seivright R; Cardona D; Burzawa J; Hnatyszyn HJ Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3406-11. PubMed ID: 11904403 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 gene expression by retroviral vector-mediated small-guide RNAs that direct specific RNA cleavage by tRNase ZL. Habu Y; Miyano-Kurosaki N; Kitano M; Endo Y; Yukita M; Ohira S; Takaku H; Nashimoto M; Takaku H Nucleic Acids Res; 2005; 33(1):235-43. PubMed ID: 15647506 [TBL] [Abstract][Full Text] [Related]
11. Cooperative and specific binding of Vif to the 5' region of HIV-1 genomic RNA. Henriet S; Richer D; Bernacchi S; Decroly E; Vigne R; Ehresmann B; Ehresmann C; Paillart JC; Marquet R J Mol Biol; 2005 Nov; 354(1):55-72. PubMed ID: 16236319 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of HIV-1 in CEM cells by a potent TAR decoy. Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112 [TBL] [Abstract][Full Text] [Related]
13. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA. Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965 [TBL] [Abstract][Full Text] [Related]
14. The middle to 3' end of the HIV-1 vif gene sequence is important for vif biological activity and could be used for antisense oligonucleotide targets. Barnor JS; Miyano-Kurosaki N; Takaku H; Yamaguchi K; Sakamoto A; Ishikawa K; Yamamoto N; Osei-Kwasi M; Ofori-Adjei D Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):1745-61. PubMed ID: 16438045 [TBL] [Abstract][Full Text] [Related]
15. Human cytosolic tRNase ZL can downregulate gene expression through miRNA. Elbarbary RA; Takaku H; Uchiumi N; Tamiya H; Abe M; Nishida H; Nashimoto M FEBS Lett; 2009 Oct; 583(19):3241-6. PubMed ID: 19751732 [TBL] [Abstract][Full Text] [Related]
16. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. Pacchia AL; Adelson ME; Kaul M; Ron Y; Dougherty JP Virology; 2001 Mar; 282(1):77-86. PubMed ID: 11259192 [TBL] [Abstract][Full Text] [Related]
17. Effective suppression of HIV-1 gene expression by a mammalian tRNA 3' processing endoribonuclease and external guide sequence oligozymes. Kitano M; Barnor JS; Miyano-Kurosaki N; Endo Y; Yukita M; Takeuchi H; Tamura Y; Takai K; Nashimoto M; Takaku H Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):719-22. PubMed ID: 11563100 [TBL] [Abstract][Full Text] [Related]
18. Molecular approaches to inhibit HIV-1 tat expression and functions. Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG Year Immunol; 1993; 7():199-204. PubMed ID: 8396820 [No Abstract] [Full Text] [Related]
20. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells. Chang LJ; Zhang C Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]